DE2460929A1 - Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung - Google Patents

Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Info

Publication number
DE2460929A1
DE2460929A1 DE19742460929 DE2460929A DE2460929A1 DE 2460929 A1 DE2460929 A1 DE 2460929A1 DE 19742460929 DE19742460929 DE 19742460929 DE 2460929 A DE2460929 A DE 2460929A DE 2460929 A1 DE2460929 A1 DE 2460929A1
Authority
DE
Germany
Prior art keywords
group
ethyl
general formula
propyl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19742460929
Other languages
German (de)
English (en)
Other versions
DE2460929C2 (US06265458-20010724-C00056.png
Inventor
Wilhelm Dr Konz
Richard Dr Reichl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Priority to DE19742460929 priority Critical patent/DE2460929A1/de
Priority to AT904575A priority patent/AT341540B/de
Priority to LU73972A priority patent/LU73972A1/xx
Priority to SU752197999A priority patent/SU603340A3/ru
Priority to DD190116A priority patent/DD124984A5/xx
Priority to AU87547/75A priority patent/AU501889B2/en
Priority to FI753543A priority patent/FI62089C/fi
Priority to DK571875A priority patent/DK137677C/da
Priority to GR49628A priority patent/GR59204B/el
Priority to US05/641,550 priority patent/US3998953A/en
Priority to RO7584245A priority patent/RO68381A/ro
Priority to CS758669A priority patent/CS191289B2/cs
Priority to CH1643275A priority patent/CH628346A5/de
Priority to YU03234/75A priority patent/YU39004B/xx
Priority to PH17894A priority patent/PH11810A/en
Priority to NZ179599A priority patent/NZ179599A/xx
Priority to BG7500032887A priority patent/BG25518A3/xx
Priority to FR7539174A priority patent/FR2294706A1/fr
Priority to NL7514837A priority patent/NL7514837A/xx
Priority to CA242,131A priority patent/CA1036159A/en
Priority to GB52168/75A priority patent/GB1517710A/en
Priority to ZA757865A priority patent/ZA757865B/xx
Priority to JP50151721A priority patent/JPS5188995A/ja
Priority to IE2787/75A priority patent/IE43208B1/en
Priority to BE162965A priority patent/BE836898A/xx
Priority to IL48697A priority patent/IL48697A/xx
Priority to NO754317A priority patent/NO144928C/no
Priority to SE7514477A priority patent/SE420493B/xx
Priority to HU75BO1590A priority patent/HU174673B/hu
Priority to PL1975185740A priority patent/PL99165B1/pl
Priority to ES443738A priority patent/ES443738A1/es
Publication of DE2460929A1 publication Critical patent/DE2460929A1/de
Priority to ES451457A priority patent/ES451457A1/es
Priority to DK123677A priority patent/DK138455C/da
Application granted granted Critical
Publication of DE2460929C2 publication Critical patent/DE2460929C2/de
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19742460929 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung Granted DE2460929A1 (de)

Priority Applications (33)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
AT904575A AT341540B (de) 1974-12-21 1975-11-28 Verfahren zur herstellung von neuen 1,3-dialkyl-7-aminoalkylxanthinen
LU73972A LU73972A1 (US06265458-20010724-C00056.png) 1974-12-21 1975-12-09
SU752197999A SU603340A3 (ru) 1974-12-21 1975-12-11 Способ получени производных ксантина или их солей
DD190116A DD124984A5 (US06265458-20010724-C00056.png) 1974-12-21 1975-12-12
AU87547/75A AU501889B2 (en) 1974-12-21 1975-12-15 Xanthine derivatives
FI753543A FI62089C (fi) 1974-12-21 1975-12-16 Foerfarande foer framstaellning av pao det perifera blodomloppet verkande 7-(n-(3-fenoxi-2-hydroxipropyl)-n-amino)-1,3-dialkyl-xantinderivat
DK571875A DK137677C (da) 1974-12-21 1975-12-16 Analogifremgangsmaade til fremstilling af basisk substitueredexanthinderivater eller syreadditionssalte heraf
GR49628A GR59204B (en) 1974-12-21 1975-12-17 New xanthin derivatives and method for their preparation and use
US05/641,550 US3998953A (en) 1974-12-21 1975-12-17 1,3,7-Trisubstitued xanthine peripheral vasodilators
CS758669A CS191289B2 (en) 1974-12-21 1975-12-18 Method of producing 7-substituted 1,3-dialkyl-xanthines
CH1643275A CH628346A5 (de) 1974-12-21 1975-12-18 Verfahren zur herstellung neuer xanthinderivate.
YU03234/75A YU39004B (en) 1974-12-21 1975-12-18 Process for preparing new xanthine derivatives
RO7584245A RO68381A (ro) 1974-12-21 1975-12-18 Procedeu pentru prepararea unor noi derivati ai xantinei
IL48697A IL48697A (en) 1974-12-21 1975-12-19 1,3,7-trisubstituted xanthine derivatives,their preparatioand pharmaceutical compositions containing them
BG7500032887A BG25518A3 (en) 1974-12-21 1975-12-19 A method of obtaining xantain derivatives
PH17894A PH11810A (en) 1974-12-21 1975-12-19 1,3,7-trisubstituted xanthine peripheral vasodilators
NL7514837A NL7514837A (nl) 1974-12-21 1975-12-19 Werkwijze ter bereiding van nieuwe xanthinederi- vaten en van preparaten, die deze xanthinederi- vaten bevatten.
CA242,131A CA1036159A (en) 1974-12-21 1975-12-19 Xanthine derivatives, process for production and use thereof
GB52168/75A GB1517710A (en) 1974-12-21 1975-12-19 Xanthine derivatives
ZA757865A ZA757865B (en) 1974-12-21 1975-12-19 Improvements relating to xanthine derivatives
JP50151721A JPS5188995A (US06265458-20010724-C00056.png) 1974-12-21 1975-12-19
IE2787/75A IE43208B1 (en) 1974-12-21 1975-12-19 Xanthine derivatives
BE162965A BE836898A (fr) 1974-12-21 1975-12-19 Nouveaux derives de la xanthine, leur procede de preparation et leur utilisation
NZ179599A NZ179599A (en) 1974-12-21 1975-12-19 Xanthine derivatives, and pharmaceutical compositions containing such
NO754317A NO144928C (no) 1974-12-21 1975-12-19 Analogifremgangsmaate for fremstilling av fysiologisk aktive zantinderivater.
SE7514477A SE420493B (sv) 1974-12-21 1975-12-19 Forfarande for framstellning av nya xantinderivat
HU75BO1590A HU174673B (hu) 1974-12-21 1975-12-19 Sposob poluchenija novykh proizvodnykh ksantina
FR7539174A FR2294706A1 (fr) 1974-12-21 1975-12-19 Nouveaux derives de la xanthine, leur procede de preparation et leur utilisation
PL1975185740A PL99165B1 (pl) 1974-12-21 1975-12-20 Sposob wytwarzania nowych pochodnych ksantyny
ES443738A ES443738A1 (es) 1974-12-21 1975-12-20 Procedimiento para la preparacion de nuevos derivados de xantina.
ES451457A ES451457A1 (es) 1974-12-21 1976-09-11 Procedimiento para la preparacion de nuevos derivados de xantina.
DK123677A DK138455C (da) 1974-12-21 1977-03-21 Analogifremgangsmaade til fremstilling af basisk substitueredexanthinderivater eller syreadditionssalte heraf

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742460929 DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Publications (2)

Publication Number Publication Date
DE2460929A1 true DE2460929A1 (de) 1976-06-24
DE2460929C2 DE2460929C2 (US06265458-20010724-C00056.png) 1987-12-17

Family

ID=5934312

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742460929 Granted DE2460929A1 (de) 1974-12-21 1974-12-21 Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung

Country Status (31)

Country Link
US (1) US3998953A (US06265458-20010724-C00056.png)
JP (1) JPS5188995A (US06265458-20010724-C00056.png)
AT (1) AT341540B (US06265458-20010724-C00056.png)
AU (1) AU501889B2 (US06265458-20010724-C00056.png)
BE (1) BE836898A (US06265458-20010724-C00056.png)
BG (1) BG25518A3 (US06265458-20010724-C00056.png)
CA (1) CA1036159A (US06265458-20010724-C00056.png)
CH (1) CH628346A5 (US06265458-20010724-C00056.png)
CS (1) CS191289B2 (US06265458-20010724-C00056.png)
DD (1) DD124984A5 (US06265458-20010724-C00056.png)
DE (1) DE2460929A1 (US06265458-20010724-C00056.png)
DK (1) DK137677C (US06265458-20010724-C00056.png)
ES (2) ES443738A1 (US06265458-20010724-C00056.png)
FI (1) FI62089C (US06265458-20010724-C00056.png)
FR (1) FR2294706A1 (US06265458-20010724-C00056.png)
GB (1) GB1517710A (US06265458-20010724-C00056.png)
GR (1) GR59204B (US06265458-20010724-C00056.png)
HU (1) HU174673B (US06265458-20010724-C00056.png)
IE (1) IE43208B1 (US06265458-20010724-C00056.png)
IL (1) IL48697A (US06265458-20010724-C00056.png)
LU (1) LU73972A1 (US06265458-20010724-C00056.png)
NL (1) NL7514837A (US06265458-20010724-C00056.png)
NO (1) NO144928C (US06265458-20010724-C00056.png)
NZ (1) NZ179599A (US06265458-20010724-C00056.png)
PH (1) PH11810A (US06265458-20010724-C00056.png)
PL (1) PL99165B1 (US06265458-20010724-C00056.png)
RO (1) RO68381A (US06265458-20010724-C00056.png)
SE (1) SE420493B (US06265458-20010724-C00056.png)
SU (1) SU603340A3 (US06265458-20010724-C00056.png)
YU (1) YU39004B (US06265458-20010724-C00056.png)
ZA (1) ZA757865B (US06265458-20010724-C00056.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337254A (en) * 1977-08-23 1982-06-29 Burroughs Wellcome Co. Pharmaceutical compositions
DE3113880A1 (de) * 1981-04-07 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von coffein
IT1174773B (it) * 1983-07-29 1987-07-01 Medosan Ind Biochimi Attivita' antiaggregante piastrinica e broncolitica della 7-(1-metil-5-p-metilbenzoilpirrol-2-acetamidoetil)teofillina
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) * 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
US5620676A (en) * 1994-03-08 1997-04-15 The United States Of America As Represented By The Department Of Health And Human Services Biologically active ATP analogs
US5789416B1 (en) * 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives
WO1999031101A1 (en) * 1997-12-17 1999-06-24 University Of South Florida Adenosine receptor antagonists with improved bioactivity
US6576619B2 (en) 1999-05-24 2003-06-10 Cv Therapeutics, Inc. Orally active A1 adenosine receptor agonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1230663A (US06265458-20010724-C00056.png) * 1968-12-10 1971-05-05
US3728346A (en) * 1971-07-16 1973-04-17 Degussa Hydroxyphenylhydroxyalkylaminoalkyltheophyllines
JPS5132638B2 (US06265458-20010724-C00056.png) * 1972-07-13 1976-09-14

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS ERMITTELT *

Also Published As

Publication number Publication date
CH628346A5 (de) 1982-02-26
CS191289B2 (en) 1979-06-29
BE836898A (fr) 1976-06-21
SE7514477L (sv) 1976-06-22
DK137677B (da) 1978-04-17
DK137677C (da) 1978-09-25
FI62089B (fi) 1982-07-30
ATA904575A (de) 1977-06-15
YU39004B (en) 1983-12-31
BG25518A3 (en) 1978-10-10
DE2460929C2 (US06265458-20010724-C00056.png) 1987-12-17
NL7514837A (nl) 1976-06-23
HU174673B (hu) 1980-03-28
FI62089C (fi) 1982-11-10
CA1036159A (en) 1978-08-08
AT341540B (de) 1978-02-10
IL48697A (en) 1979-07-25
FI753543A (US06265458-20010724-C00056.png) 1976-06-22
ES451457A1 (es) 1977-10-01
RO68381A (ro) 1982-02-26
US3998953A (en) 1976-12-21
NO144928B (no) 1981-08-31
GR59204B (en) 1977-11-26
FR2294706B1 (US06265458-20010724-C00056.png) 1978-12-01
ES443738A1 (es) 1977-04-16
AU8754775A (en) 1977-06-23
IE43208L (en) 1976-06-21
NZ179599A (en) 1978-03-06
IE43208B1 (en) 1981-01-14
DD124984A5 (US06265458-20010724-C00056.png) 1977-03-23
PL99165B1 (pl) 1978-06-30
NO144928C (no) 1981-12-09
ZA757865B (en) 1977-08-31
JPS5188995A (US06265458-20010724-C00056.png) 1976-08-04
FR2294706A1 (fr) 1976-07-16
NO754317L (US06265458-20010724-C00056.png) 1976-06-22
DK571875A (da) 1976-06-22
GB1517710A (en) 1978-07-12
SE420493B (sv) 1981-10-12
IL48697A0 (en) 1976-02-29
PH11810A (en) 1978-07-10
SU603340A3 (ru) 1978-04-15
AU501889B2 (en) 1979-07-05
LU73972A1 (US06265458-20010724-C00056.png) 1977-02-15
YU323475A (en) 1982-08-31

Similar Documents

Publication Publication Date Title
DE3685608T2 (de) 8-phenylxanthine.
DE2558501A1 (de) Verfahren zur herstellung von alpha, alpha, alpha-trisubstituierten acetamiden, acetonitrilen und methanen und diese verbindungen enthaltende pharmazeutische zubereitungen
DE2460929A1 (de) Neue xanthinderivate, verfahren zu ihrer herstellung und ihre anwendung
DD142048A5 (de) Verfahren zur herstellung von substituierten 2-phenylimino-imidazolidinen
DE2630060A1 (de) 2-brom-6-fluor-n-2-imidazolidinyliden- benzamin, dessen saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu dessen herstellung
DE3326724A1 (de) In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE1940566C3 (de) 1- (2-Nitrilophenoxy)-2-hydroxy-3äthylaminopropan, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel
DE3730718A1 (de) Tetracyclische chinazolinderivate, herstellung und verwendung
DE1620541B2 (de) Neue in 3-Stellung substituierte 6,8-Dibrom-tetrahydro-chinazoline
EP0117531B1 (de) N-(3-Trifluormethylphenyl)-N'-propargylpiperazin, seine Herstellung und Verwendung
DE2208368C3 (de) 1 -Phenyl-S-hydroxy-S-methyltriazene und Verfahren zu ihrer Herstellung
DE2721830A1 (de) Arzneipraeparate mit einem gehalt an isothioharnstoffderivaten
DE2831671A1 (de) Neue substituierte 2-phenylamino-imidazoline-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
DE1950351C3 (de) l-(2-Cyano-5-methylphenoxy)-2-hydroxy-3-aIkylaminopropane, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE1618160C3 (de) l-(2-Äthinylphenoxy)-2-hydroxy-3alkylaminopropane, ihre physiologisch verträglichen Säureadditionssalze, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
DE2757929A1 (de) Neue pyrido-eckige klammer auf 1,2-a eckige klammer zu -v-triazolo- eckige klammer auf 4,5-d eckige klammer zu pyrimidinone, deren salze und verfahren zu deren herstellung
AT325053B (de) Verfahren zur herstellung von neuen tetrahydropyrimidinen, imidazolinen und tetrahydro-1,3-diazepinen und deren saureadditionssalzen
DE2207460A1 (de) Neues lungentherapeutikum
AT311350B (de) Verfahren zur Herstellung von neuen 1,2,3,6,-Tetrahydro-4-pyridylmethyl-carbonsäureestern, deren Säureadditionssalzen und quaternären Ammoniumverbindungen
DE2210620C2 (de) Bis-Phenoxypropanolamine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1518691C (de) 9 (gamma Methylamino propyl) 9,10 dihydro 9 10 athano anthrazen, seine SaI ze und Verfahren zu deren Herstellung
DE1203781B (de) Verfahren zur Herstellung von trypanocid wirksamen Phenanthridiniumderivaten
AT339905B (de) Verfahren zur herstellung von neuen piperidinderivaten und deren salzen
DE3300477A1 (de) Neue heterocyclische verbindungen, ihre herstellung und verwendung
DE3712385A1 (de) 2-(phenylimino)imidazolidine

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee